• Mineralys Therapeutics Chief Commercial Officer Eric Warren sold 7,438 shares on Sept. 21, 2026 at USD 28.12.
• The sale followed the exercise of stock options for 7,438 shares at USD 13.24.
• Warren held 38,400 shares after the transactions.
• He held 230,563 stock options after the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001916048-26-000014), on September 22, 2026, and is solely responsible for the information contained therein.